281 related articles for article (PubMed ID: 28578695)
1. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson's disease.
Singh P; Hanson PS; Morris CM
BMC Neurosci; 2017 Jun; 18(1):46. PubMed ID: 28578695
[TBL] [Abstract][Full Text] [Related]
2. The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases.
Liu H; Xu S; Wang C; Deng Y; Xu B; Yang T; Sun J; Liu W
Neuroscience; 2022 Nov; 504():79-92. PubMed ID: 36202276
[TBL] [Abstract][Full Text] [Related]
3. Chlorpyrifos activates cell pyroptosis and increases susceptibility on oxidative stress-induced toxicity by miR-181/SIRT1/PGC-1α/Nrf2 signaling pathway in human neuroblastoma SH-SY5Y cells: Implication for association between chlorpyrifos and Parkinson's disease.
Zhao MW; Yang P; Zhao LL
Environ Toxicol; 2019 Jun; 34(6):699-707. PubMed ID: 30835941
[TBL] [Abstract][Full Text] [Related]
4. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide.
Albani D; Polito L; Batelli S; De Mauro S; Fracasso C; Martelli G; Colombo L; Manzoni C; Salmona M; Caccia S; Negro A; Forloni G
J Neurochem; 2009 Sep; 110(5):1445-56. PubMed ID: 19558452
[TBL] [Abstract][Full Text] [Related]
5. Cdk5 suppression blocks SIRT1 degradation via the ubiquitin-proteasome pathway in Parkinson's disease models.
Zhang Q; Zhang P; Qi GJ; Zhang Z; He F; Lv ZX; Peng X; Cai HW; Li TX; Wang XM; Tian B
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1443-1451. PubMed ID: 29571747
[TBL] [Abstract][Full Text] [Related]
6. Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson's disease.
Maszlag-Török R; Boros FA; Vécsei L; Klivényi P
Sci Rep; 2021 May; 11(1):10677. PubMed ID: 34021216
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration.
Singh P; Hanson PS; Morris CM
Parkinsons Dis; 2017; 2017():2643587. PubMed ID: 28634568
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 mediates salidroside-elicited protective effects against MPP
Wang CY; Sun ZN; Wang MX; Zhang C
Cell Biol Int; 2018 Jan; 42(1):84-94. PubMed ID: 28851138
[TBL] [Abstract][Full Text] [Related]
9. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways.
Chong ZZ; Maiese K
Curr Neurovasc Res; 2008 Aug; 5(3):159-70. PubMed ID: 18691073
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 protects against α-synuclein aggregation by activating molecular chaperones.
Donmez G; Arun A; Chung CY; McLean PJ; Lindquist S; Guarente L
J Neurosci; 2012 Jan; 32(1):124-32. PubMed ID: 22219275
[TBL] [Abstract][Full Text] [Related]
12. Activation of Sirt1/PGC1α pathway attenuates neuroinflammation injury in Parkinson's disease.
Yang Y; Gong Z; Wang Z; Lu Y
J Recept Signal Transduct Res; 2022 Feb; 42(1):67-70. PubMed ID: 33172325
[TBL] [Abstract][Full Text] [Related]
13. miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
Wang Z; Sun L; Jia K; Wang H; Wang X
Neurosci Lett; 2019 May; 701():226-233. PubMed ID: 30826419
[TBL] [Abstract][Full Text] [Related]
14. Modulation in miR-200a/SIRT1axis is associated with apoptosis in MPP
Salimian N; Peymani M; Ghaedi K; Nasr Esfahani MH
Gene; 2018 Oct; 674():25-30. PubMed ID: 29936262
[TBL] [Abstract][Full Text] [Related]
15. SIRT1: new avenues of discovery for disorders of oxidative stress.
Chong ZZ; Shang YC; Wang S; Maiese K
Expert Opin Ther Targets; 2012 Feb; 16(2):167-78. PubMed ID: 22233091
[TBL] [Abstract][Full Text] [Related]
16. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein.
Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W
Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361
[TBL] [Abstract][Full Text] [Related]
17. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
Shavali S; Combs CK; Ebadi M
Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 pathway in Parkinson's disease: a faraway snapshot but so close.
Batiha GE; Al-Kuraishy HM; Al-Gareeb AI; Elekhnawy E
Inflammopharmacology; 2023 Feb; 31(1):37-56. PubMed ID: 36580159
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
20. Sirtuins in cognitive ageing and Alzheimer's disease.
Braidy N; Jayasena T; Poljak A; Sachdev PS
Curr Opin Psychiatry; 2012 May; 25(3):226-30. PubMed ID: 22327552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
